ehealth digital library

Digital library of
the Tanzania
health
community

Items where Subject is "Malaria > Vaccines"

Up a level
Export as [feed] RSS
Group by: Creators | Item Type
Jump to: A | B | C | D | E | G | H | I | J | K | L | M | O | Q | R | S | T | V | W
Number of items at this level: 56.

A

(2014) Malaria Vaccine Updates and Policy Framework. In: NATIONAL MALARIA FORUM, 25th April 2014, Golden Jubilee Tower in Dar es Salaam. (Unpublished)

(2013) Randomized, Controlled Trial of the Long Term Safety, Immunogenicity and Efficacy of RTS,S/AS02(D) Malaria Vaccine in Infants Living in a Malaria-Endemic Region. Malaria journal, 12. p. 11. ISSN 1475-2875

(2012) Role of Malaria Vaccines in Malaria Elimination. In: Malaria Control Forum, 24 April, 2012., Blue Pearl Hotel, Dar es Salaam. (Unpublished)

(2012) A phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants. The New England journal of medicine, 367 (24). pp. 2284-95. ISSN 1533-4406

(2011) First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. The New England journal of medicine, 365 (20). pp. 1863-75. ISSN 1533-4406

(2015) The Effect of Immunization Schedule with the Malaria Vaccine Candidate RTS,S/AS01E on Protective Efficacy and Anti-Circumsporozoite Protein Antibody Avidity in African Infants. Malaria Journa. ISSN 1475-2875

Dynamics of P. Falciparum Gametocytemia in Symptomatic Patients in an Area of Intense Perennial Transmission in Tanzania. The American journal of tropical medicine and hygiene, 63 (3-4). pp. 199-203. ISSN 0002-9637

Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. The American journal of tropical medicine and hygiene, 63 (4). pp. 199-203. ISSN 0002-9637

(2009) Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet, 374 (9700). pp. 1533-1542. ISSN 1474-547X

(2011) Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. The Lancet infectious diseases, 11 (10). pp. 741-749. ISSN 1474-4457

B

(2012) Tanzanian Institution in Malaria Fight. Mwananchi Communication.

(2014) Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe. Malaria journal. ISSN 1475-2875

(2014) Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine. Malaria Journal. ISSN 1475-2875

C

(2011) Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. PloS one, 6 (7). pp. 1-11. ISSN 1932-6203

(2014) A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila. PloS one, 9 (1). e87198. ISSN 1932-6203

D

(2012) Malaria Vaccine Less Effective Than Expected. Tanzania Standard Newspapers.

(2011) Malaria Vaccine Trial Raises Hope in Curing Patients. Tanzania Standard Newspapers.

E

(2012) Malaria Parasite Diversity and Transmission Intensity Affect Development of Parasitological Immunity in a Mathematical model. Malaria journal, 11. p. 419. ISSN 1475-2875

G

(2015) Costing RTS,S Introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A Generalizable Approach Drawing on Publicly Available Data. Vaccine. ISSN 1873-2518

(2016) The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan. PLoS medicine, 13 (4). e1001994. ISSN 1549-1676

H

(1995) Immunological markers of childhood fevers in an area of intense and perennial malaria transmission. Clinical and experimental immunology, 100 (1). pp. 59-66. ISSN 0009-9104

(2009) Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bulletin of the World Health Organization, 87 (2). pp. 123-129. ISSN 1564-0604

I

(2016) Intervention Thematic Group Malaria Research Work in Bagamoyo. In: Symposium – 10 Years of IHI at Bagamoyo, Friday 19th February 2016, Bagamoyo. (Unpublished)

(2000) Molecular Diversity and Immunological Properties of the "Plasmodium falciparum" : Merozoite Surface Protein 2(MSP2). Doctoral thesis, University of Basel.

J

(2016) 1631: Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (pfspz vaccine) in Tanzanian Adults. In: Symposium – 10 Years of IHI at Bagamoyo, Friday 19th February 2016, Bagamoyo. (Unpublished)

K

(2012) Malaria Vaccine(RTS's)Highlights Positive Results. Business Times Limited.

L

(2011) Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malaria journal, 10. p. 224. ISSN 1475-2875

(2011) Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children. Malaria journal, 10 (222). pp. 1-7. ISSN 1475-2875

(2012) Big Hope for Malaria Vaccine in New Study. Mwananchi Communication.

(2012) Experts: Don't Lower Your Guard Because of Vaccine. Mwananchi Communication.

(2013) Community Perceptions on the Secondary Health Benefits Established by Malaria Vaccine trials (RTS,S phase 2 and phase 3) At the Korogwe Site in North Eastern Tanzania. Malaria journal, 12. p. 157. ISSN 1475-2875

(2010) Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children. PloS one, 5 (11). e14090. ISSN 1932-6203

M

(2008) Stochastic Simulation Models of Plasmodium Falciparum Malaria Epidemiology and Control. Doctoral thesis, University of Basel.

(2014) Effect of Ingested Human Antibodies Induced by RTS, S/AS01 Malaria Vaccination in Children on Plasmodium Falciparum oocyst Formation and Sporogony in Mosquitoes. Malaria journal, 13 (1). p. 263. ISSN 1475-2875

(2008) Expression of "Plasmodium Falciparum Var" Genes in Naturally Infected Children from Tanzania. Doctoral thesis, University of Basel.

(2013) Experience and Challenges from Clinical Trials with Malaria Vaccines in Africa. Malaria journal, 12. p. 86. ISSN 1475-2875

O

(2013) Identification of VAR2CSA Domain-Specific Inhibitory Antibodies of the Plasmodium Falciparum Erythrocyte Membrane Protein 1 Using a Novel Flow Cytometry Assay. Clinical and vaccine immunology : CVI, 20 (3). pp. 433-42. ISSN 1556-679X

(2014) Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children. PloS one, 9 (12). e115126. ISSN 1932-6203

Q

(2013) Malaria Vaccine Efficacy Proposed. Mwananchi Communication.

R

(2015) Assessment of Parental Perception of Malaria Vaccine in Tanzania. Malaria journal, 14 (1). p. 355. ISSN 1475-2875

(2015) Assessment of Parental Perception of Malaria Vaccine in Tanzania. Malaria journal, 14 (1). p. 355. ISSN 1475-2875

(2016) Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania. Malaria Journal. ISSN 1475-2875

S

(2013) Design of PfSPZ (IV) Vaccine IHI, Bagamoyo, Tanzania. In: Sanaria Symposium 13th November 2013. (Unpublished)

(2013) Design of PfSPZ-CVac (IV)IHI, Bagamoyo, Tanzania. In: Sanaria Symposium 13th November 2013. (Unpublished)

(2013) Overview of PfSPZ Studies in Tanzania and Africa. In: Sanaria Symposium 16th November 2013.

(2011) Malaria Vaccine Coming Soon. Mwananchi Communication.

T

(2009) Use of Synthetic Carbohydrates as Vaccine Components and Biomedical Research Tools. Doctoral thesis, University of Basel.

(2011) Malaria Vaccine Trial Produces Positive Results. Tanzania Standard Newspapers.

(2010) Simulation of the Costs and Consequences of Potential Vaccines for Plasmodium Falciparum Malaria. Doctoral thesis, University of Basel.

(2011) Malaria Vaccine Coming. Mwananchi Communication.

(2011) Fresh Hopes as Experts Express Optimism on Malaria Vaccine. The Guardian Limited.

(2015) Antibody Titre as a Surrogate of Protection of the First Malaria Subunit Vaccine, RTS,S/AS01. Lancet Infectious Diseases. ISSN 1473-3099

V

(2013) Malaria Vaccine "Beginning to Fade". Nation Group.

W

(2014) A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy from Phase 2 Trials of the RTS,S Malaria Vaccine. BMC medicine, 12 (1). p. 117. ISSN 1741-7015

(2015) Immunogenicity of the RTS,S/AS01 Malaria Vaccine and Implications for Duration of Vaccine Efficacy: Secondary Analysis of Data from a phase 3 Randomised Controlled Trial. The Lancet. Infectious diseases. ISSN 1474-4457

(2015) Immunogenicity of the RTS,S/AS01 Malaria Vaccine and Implications for Duration of Vaccine Efficacy: Secondary Analysis of Data from a Phase 3 Randomised Controlled Trial. Lancet Infectious Diseases. ISSN 1473-3099

This list was generated on Sat Nov 18 04:41:34 2017 UTC.